Protara Therapeutics Announces Appointment of Jane Huang, M.D. to Board of Directors

NEXT STORY
BriaCell Therapeutics Announces Proceeds of US$12.88 Million from Warrant Exercises
PREV STORY
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in June
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Atara Biotherapeutics to Participate in the 37th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), ...

author_avatar
NASDAQ Market News

ZIOPHARM to Present at the Jefferies 2017 Global Healthcare Conference

BOSTON, June 02, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that ...

author_avatar
NASDAQ Market News

Innate Pharma in-licenses OREGA biotech’s first-in-class anti-CD39 checkpoint inhibitor program

This program, currently in preclinical development, aims at developing an anti-CD39 mAb; Targeting the ...

author_avatar
NASDAQ Market News